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Epilepsy is one of the most common neurological diseases affecting at least 50 million
people worldwide. Valproic acid (VPA) is a widely used antiepileptic medication for both
generalized and partial seizures of epilepsy. The objective of the study was to investigate
the anti-mutagenic and anti-histopathologic effects of royal jelly (RJ) on VPA-induced
genotoxicity and nephrotoxicity in male albino mice (Mus musculus). 80 Mice were used
for 21 days; they were divided into eight groups, (G1) served as normal control group, G2
received VPA (100 mg/kg) and (G3eG5) received RJ at doses 50, 100 and 200 mg/kg respec-
tively. While (G6eG8) were administrated RJ simultaneously with VPA. In RJ treated mice at
doses of 50 and 100 mg/kg, the kidney sections showed normal histological structure with
non significant changes in chromosomal aberrations (CA) and mitotic index (MI), while RJ
at dose of 200 mg/kg showed mild inflammatory cells infiltration and hyperemic glomeruli
but not highly significant changes in CA and MI. The cortex of VPA treated mice revealed
congested glomeruli with inflammatory cells infiltration, and marked degeneration of
almost structures of the glomeruli including some vacuoles in mesangial cells with dark
mesangial substances on the ultrastructure level. Some proximal tubules showed degen-
eration of microvilli on the apical parts of some cells. Cells of the distal tubules attained
obliterated lumen and vacuolated lining epithelium. The results also revealed that valproic
acid induced a high frequency of CA in bone marrow cells of mice and MI was significantly
decreased indicating bone marrow cytotoxicity. The treatment of mice with RJ at doses 50,
100 and 200 mg/kg for 21 days simultaneously with VPA resulted in abating the histological
alterations in renal tissues with significant reduction in chromosomal aberrations, for
doses of 50 and 100 mg/kg, and elevation in mitotic index (P < 0.05). RJ at doses 50 and
100 mg/kg appeared more potent in exerting the ameliorative effect.
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acid or dipropylacetic acid (Aktas‚ et al., 2010), is commonly
prescribed worldwide as a broad spectrum antiepileptic drug
with specific indications formany forms of epilepsy andmany
types of seizures affecting both children and adults (Silva
et al., 2008). VPA is usually well tolerated. Nevertheless,
along with the desired effects, VPA therapy can induce side
effects such as dyspepsia, obesity, hematological toxicity,
teratogenicity, idiosyncratic hepatotoxicity and important
endocrine dysfunctions (Dutheil et al., 2008; Verrotti et al.,
2005; Zhang and Wang, 2009).
Verrotti et al. (2000) indicated that patients treated with
VPA had an impairment of renal tubular functions. As well,
Altunbas‚ak et al. (2001) reported that epileptic children who
were ambulatory and depend on VPAmonotherapy developed
clinically insignificant proximal renal tubular dysfunction.
Recently, the experiment of Mazaheri et al. (2011) concerning
children on anti-epileptic treatment with valproic acid recor-
ded signs of renal tubular dysfunction, reflected by N-acetyl
beta glucosaminidase/creatinine (NAG/Cr) activity index.
Kortenhorst et al. (2009) reported that VPA treatment
caused significant nuclear alterations in normal drug-filtering
organs (liver and kidney tissues). VPA further induced a
depletion of several members of the structural maintenance
of chromatin (SMC) proteins, SMC-associated proteins, DNA
methyltransferase and heterochromatin proteins (Marchion
et al., 2005).
Long-term mono-therapy or poly-therapy with anti-
epileptic drugs leads to the formation of toxic metabolites of
these drugs, reactive oxygen species and free radicals
(Witczak et al., 2008). In particular, reactive oxygen species
and free radicals show genotoxic activity (Mitchell et al., 2004).
In order to overcome the potential harmful effect of free
radicals and to reduce the damage by oxidants, many natural
substances have been tried as antioxidants.
Royal jelly (RJ) is a honeybee product secreted from the
hypopharyngeal and mandibular glands of the worker hon-
eybees (Silici et al., 2009). It is a mixture that contains protein,
glucose, lipid, vitamins, minerals (Nakajima et al., 2009),
aspartic acid, gelatin, sterols, phosphorous compounds,
acetylcholine, nucleic acids, and numerous trace ingredients,
which are all important in RJ’s documented therapeutic and
nutritional properties (C¸avus‚oglu et al., 2009). These in-
gredients are in the form of 65% water, 12% crude protein and
10% monosaccharides. The remainder of the royal jelly is
composed of an ether-soluble fraction of fatty acids
(Spannhoff et al., 2011).
Previous studies have shown that RJ has number of phys-
iological effects, such as anti-inflammatory, anti-tumor,
antimetastatic effect (Kimura et al., 2003) anti-allergic, anti-
oxidant activities (Guo et al., 2008), antibacterial, vasodilative
and hypotensive activities, disinfectant action and anti-
hypercholesterolemic activity (Ramadan and Al-Ghamdi,
2012).
RJ has received particular attention because of studies that
have reported that it is a highly efficient antioxidant and has
free radical scavenging capacity (Cemek et al., 2010) and usedfor decreasing the toxic effects of chemical agents (El-Nekeety
et al., 2007). Several studies revealed biological evidence sup-
ports the use of RJ in the treatment of chemical induced
genotoxicity (Tu¨rkmen et al., 2009). It has a DNA-protective
effect (Inoue et al., 2003) and also stimulates bone marrow
formation (Narita et al., 2006). Abd El-Monem (2011) revealed
that RJ caused a significant recovery in antioxidant status of
reduced glutathione (GSH) and a significant inhibition of
malondialdehyde (MDA) production and ameliorated DNA
damage and genotoxicity induced by malathion in rat cells.
Therefore, the present study was undertaken to evaluate
the possible protective effects of royal jelly against valproic
acid induced chromosomal abnormalities in bone marrow
cells and histological alterations in kidney tissue of male mice
(Mus musculus).2. Materials and methods
2.1. Chemicals
Sodium valproate (salt of Valproic acid) was purchased from
pharmacy in the form of tablets with trade name Depakine
(Sanofi Synthelabo, France), each containing 200mg of sodium
valproate dissolved in distilled water according to the used
dose. Royal Jelly was purchased from pharmacy in the form of
capsules (Techno Pharma Egypt for Pharco Pharmaceuticals,
Alexandria, Egypt) each containing 340 mg of natural royal
jelly dissolved in distilledwater according to the used dose. All
other chemicals were obtained from Sigma (St. Louis, MO,
USA).
2.2. Experimental animals
The experimental animals used in this work were 80 random
bred adult males of laboratory mice M. musculus (20e30 g in
weight). All animals were housed in plastic cages with wired
covers and kept under normal laboratory conditions. Experi-
ments were performed as per internationally followed ethical
standards and according to the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health
(Institute of Laboratory Animal Resources, 1996). The animals
were not treated with antibiotics or insecticides and fed a
standard commercial diet (ATMID Company, Egypt) and tap
water ad libitum.
2.3. Experimental design
A single dose (100 mg/kg) of VPA was selected with reference
to the dose range of the cytotoxicity and genotoxicity of VPA
(Lee et al., 2007). However, RJ concentrations used in the study
were 50, 100 and 200 mg/kg. These concentrations were
selected according to (Cemek et al., 2010).
Experimental groups were organized into eight groups
including 10 animals per each. Because colchicine is toxic, five
animals were used for cytogenetic analysis while the other
five animals were used for histopathological studies. The an-
imals of group one (G1) served as normal control receiving
0.9% of NaCl solution by intraperitoneal injection (i.p.) daily
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(i.p.) injection of VPA (100 mg/kg) daily for three weeks. In
groups 3, 4 and 5, the RJ doses 50, 100 and 200 mg/kg respec-
tively, were given to the animals through oral intubation once/
day for three weeks. The animals of the groups G6, G7 and G8
received oral administration of RJ (50, 100 and 200 mg/kg
respectively) once/day for three weeks simultaneously with
i.p. injection of VPA.2.4. Cytogenetic assay
Bone marrow cell preparations for the analysis of chromo-
somal aberrations and mitotic indices were conducted by the
colchicine-hypotonic technique. Twenty-four hours after
completion of the treatment period, five animals from each
group were sacrificed by cervical dislocation. Colchicine was
given at the dose of 4 mg/kg intraperitoneally (i.p.) at 2 h prior
to sacrifice time. The bone marrow smears of animals in each
group were prepared according to Preston et al. (1987). For
each group, slides were stained with Giemsa staining method
and 50 well spread metaphase plates/animal were analyzed
for chromosomal aberrations and the number of mitotic cells
in 1000 cells/animal. The percentage of suppressed aberrant
cells was calculated according to Shukla and Taneja (2002) as
follows:
100

% of aberrant cells in G6 or G7 or G8
% of aberrant cells in G2

 100
2.5. Histopathological assay
2.5.1. Preparation of paraffin section
At the end of the experiment, mice in each group were
sacrificed under mild anesthesia by diethyl ether and
dissected quickly to remove the kidney. Kidney tissues were
fixed in 10% buffered formalin, washed with tap water then
serial dilutions of absolute ethyl alcohol were used for
dehydration. After routine processing, paraffin wax tissue
blocks were prepared for sectioning at 4 microns thickness
by rotary microtome. The obtained tissue sections were
collected on glass slides, deparaffinized and stained by he-
matoxylin and eosin stain for histopathological examina-
tion (Bancroft and Gamble, 2002).
2.5.2. Ultrastructure preparations
Specimens from kidney were cut into small pieces measuring
about 1 mm3 and kidney biopsies were fixed in 2.5% phos-
phate buffered glutaraldehyde. Specimens were post-fixed
with 1% osmic acid and dehydrated with acetone, the semi-
thin sections of tissue samples, embedded in araldite, were
stained with toluidine blue. Then, the thin sections were
stained with uranyl acetate and lead citrate (Reynolds, 1963)
and examined with a Joel CX100 transmission electron
microscope.
2.5.3. Statistical analysis
Statistical analysis for the difference in the mean number of
chromosomal aberrations and mitotic index between groups
was carried out using the student t-test (P < 0.05 was
considered significant).3. Results
3.1. Cytogenetic assay
According to the illustrated cytogenetic results, ten structural
and numerical chromosomal aberrations were determined in
the control and the experimental groups (Fig. 1). The results
obtained in the first phase of cell cycle (24 h after sampling
time), revealed that VPA given at a dose of 100 mg/kg daily for
three weeks (G2), induced a high frequency of chromosomal
aberrations in bone marrow cells of mice when compared
with the control group (G1). The chromatid breaks and de-
letions were the most frequent chromosomal aberrations.
Other structural and numerical aberrations increased signifi-
cantly at (P < 0.05) over the control group (G1) (Table 1 and
Fig. 2), while the mitotic index was significantly decreased to
59.76  3.771, compared to control value of 80.84  1.035
(P < 0.05), indicating bone marrow cytotoxicity (Table 2).
The data illustrated in Table 1 indicated that, when RJ was
given alone at doses 50, 100 and 200mg/kg once daily for three
weeks (G3, G4 and G5, respectively), it did not induce or in-
crease the number of chromosomal aberrations over control
group (G1) like ring chromosomes, end to end association,
centric fusion, centric attenuation and endomitosis. Never-
theless, the number of chromatid breaks, chromatid de-
letions, value of total structural aberrations, value of total
numerical chromosomal aberrations, number of cells with
one aberration, percentage of incidence of aberrant cells and
number of aberration/cell increased gradually with increasing
the dose of RJ over the control group (G1) (Tables 1 and Fig. 2).
The RJ was also found to be not cytotoxic at the given doses of
50 and 100 mg/kg as there was no significant changes at
(P < 0.05) in mitotic index over G1, while RJ at dose of 200 mg/
kg showed slight cytotoxicity (Table 2).
Administration of RJ with VPA (G6, G7 and G8) indicated a
significant decrease in rates of clastogenetic changes
compared with the VPA-treated group (Tables 1 and Fig. 2).
All types of chromosomal aberrations induced by VPA
including breaks, deletions, fragments, end to end associa-
tion, centric fusion, and other multiple damages were found
to be reduced by RJ but still significantly higher than the
normal control group (G1) (Table 1). The mitotic index was
found to be increased significantly (P < 0.05) over G2 for 50
and 100 mg/kg doses, indicating their anti-cytotoxicity
towards VPA (Table 2). The percentages of aberrant cells
which were found to be 30.40  1.460 in VPA treated ani-
mals, were reduced to 18.80  0.320, 17.60  1.070 and
24.40  1.360 (P < 0.05) by RJ at doses 50, 100 and 200 mg/kg
respectively (Table 2). Also a significant decrease in the
number of aberrations per cell was observed in G6 and G7
over the VPA-treated group (G2). The suppressive effects of
RJ, at doses 50, 100 and 200 mg/kg were 38.150%, 42.100%
and 19.737%, respectively (Table 2).3.2. Histopathological assay
3.2.1. Light microscope analysis
Microscopic examination of the kidney of male mice was car-
ried out in all experimental groups after 3 weeks of treatment
Fig. 1 e (a) Metaphase spread from mouse bone marrow cells showing normal chromosomes spread. (b) Metaphase spread
from mouse bone marrow cells showing ring chromosome ([). (c) Metaphase spread from mouse bone marrow cells
showing centric fusion aberration ([). (d) Metaphase spread from mouse bone marrow cells showing a cell with more than
one aberration [deletion (white arrow), fragment (bold black arrow) and end to end association (thin black arrow)]. (e)
Metaphase spread from mouse bone marrow cells showing a cell with more than one aberration [chromatid break (thin
arrow) and chromatid gap (bold arrow). (f) Metaphase spread from mouse bone marrow cells showing centric attenuation
aberration. (g) Metaphase spread from mouse bone marrow cells showing endomitosis. (h) Metaphase spread from mouse
bone marrow cells showing polyploidy.
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ability of RJ for restoring and ameliorating these damaging
effects. Light microscopy proved more ameliorative effect at
dose 100 mg/kg, so electron microscopy was restricted to this
dose. In control mice, the microscopic examination of thekidney sections showed normal histological structure of the
renal corpuscles and renal tubules. The renal corpuscle in-
cludes the glomerulus that is a small tuft of capillaries covered
by Bowman’s capsule. The renal tubules consist of proximal
convoluted tubules, distal convoluted tubules and collecting
Table 1 e Chromosomal aberrations induced in bone marrow cells of mice after treatment with VPA and 3 different doses of royal jelly (RJ).
Groups Number of
metaphase
Structural chromosomal aberrations Numerical chromosomal
aberrations
Chromatid
break
Chromatid
deletion
Chromatid
gap
Ring
chromosome.
Fragment End to end
assoc.
Centric
fusion
Centric
attenuation
TSAa Polyploidy Endomitosis TNAa
Gr1 (saline) 250 3 (1.20) 4 (2.60) 0 0 0 0 0 1 (0.40) 8
2.20  0.860
0 4 (1.60) 4
0.80  0.200
Gr2 (VPA) 250 18 (7.20) 23 (9.20) 0 1 (0.40) 6 (2.40) 5 (2.00) 4 (1.60) 14 (5.60) 71b
14.20  1.529
3 (1.20) 12 15b
3.00  0.710
Gr3 (RJ50) 250 3 (1.20) 4 (1.60) 1 (0.40) 0 4 (1.60) 1 (0.40) 0 1 (0.40) 14c
2.80  0.860
0 3 (1.20) 3c
0.60  0.400
Gr4 (RJ100) 250 7 (2.80) 9 (3.60) 0 0 4 (1.60) 1 (0.40) 1 (0.40) 0 22b
4.40  0.510
2 (0.80) 0 2c
0.40  0.245
Gr5 (Rj200) 250 9 (3.60) 6 (2.40) 3 (1.20) 2 (0.80) 2 (0.80) 0 0 1 (0.40) 23b
4.60  0.245
6 (2.40) 3 (1.20) 9c
1.80  0.735
Gr6 (RJ50 þ VPA) 250 10 (4.00) 17 (6.80) 0 0 4 (1.60) 3 (1.20) 2 (0.80) 6 (2.40) 42d
8.40  0.600
4 (1.60) 6 (2.40) 10e
2.00  0.316
Gr7 (RJ100 þ VPA) 250 16 (6.40) 12 (4.80) 1 (0.40) 2 (0.80) 2 (0.80) 1 (0.40) 2 (0.80) 6 (2.40) 42d
8.40  0.927
1 (0.40) 9 (3.60) 10e
2.00  0.707
Gr8 (RJ200 þ VPA) 250 15 (6.00) 16 (6.40) 1 (0.40) 0 1 (0.40) 0 0 23 (9.20) 56e
11.20  1.463
6 (2.40) 8 (3.20) 14e
2.80  0.200
TSA: Total structural aberrations TNA: Total numerical aberrations.
p < 0.05 Significant.
a Mean  SE data in brackets %.
b Significant increased with ve control.
c Not significant with ve control.
d Significant decreased with þve group.
e Not significant with þve control.
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Table 2 e Clastogenetic changes induced in bone marrow cells of mice in control and treated groups.
Groups Number ofa cells
with one aberration
Number of cellsa
with more than
one aberration
Incidence ofa
aberrant cells %
Number ofa
aberration/cell
Suppressive
effect %
Mitotic indexa
Gr1 saline 4.80 þ 2.039 e 4.80 þ 2.039 0.032 þ 0.020 80.84 þ 1.035
Gr2 VPA 13.20  1.241 2.00  0.316 30.40  1.460b 0.344  0.034b 59.76  3.771b
Gr3 RJ50 3.40  0.678 e 6.80  0.680c 0.068  0.013c 71.34  0.717c
Gr4 RJ100 3.20  0.489 0.80  0.374 8.00  0.450c 0.096  0.013b 69.73  0.872c
Gr5 RJ200 6.40  0.600 e 10.80  0.750b 0.128  0.012b 62.03  1.456b
Gr6 RJ50 þ VPA. 8.60  0.510 0.80  0.374 18.80  0.320d 0.208  0.010d 38.150 62.22  0.610e
Gr7 RJ100 þ VPA. 6.40  1.288 2.00  0.447 17.60  1.070d 0.208  0.018d 42.100 64.31  0.855e
Gr8 RJ200 þ VPA. 11.00  1.673 1.20  0.800 24.40  1.360e 0.280  0.027e 19.737 58.33  0.521e
p < 0.05 Significant.
a Mean  SE data.
b Significant increased with ve control.
c Not significant with ve control.
d Significant decreased with þve group.
e Not significant with þve control.
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cuboidal epithelium, having prominent brush borders and
acidophilic cytoplasm. Distal convoluted tubules are identified
on account of simple cuboidal epithelium, clearly defined and
wider lumen than those of the proximal convoluted tubules
(Fig. 3a). In control RJ-treated mice, the microscopic examina-
tion of the kidney sections showed normal histological struc-
ture of the renal corpuscles and renal tubules, except for RJ at a
dose of 200 mg/kg that showed mild inflammatory cells infil-
tration and hyperemic glomerulus (Fig. 3b). The microscopic
examination of the kidney sections of VPA-administeredmice
showed periglomerular oedema infiltrated with a number of
inflammatory cells (Fig. 3c and d), karyomegally of some
epithelial cells lining the renal tubules (Fig. 3c and e) and hy-
peremic glomerulus (Fig. 3c, e and f). Other corpuscles showed
adhesion of the glomerular tufts with Bowman’s capsules
(Fig. 3e). Dilatation and congestion of blood vessels (Fig. 3d),
swelling of renal tubules (Fig. 3f) and degeneration of the
epithelial cells lining the renal tubules (Fig. 3g) were detected.
In addition, the endothelium of intertubular blood vesselsb
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e
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Fig. 2 e Showing the number of total structural and total numedegenerated and the muscle fibers showed hydropic degener-
ation and perivascular oedema (Fig. 3h).
Photomicrographs of kidney sections of mice treated
with VPA and RJ (200 mg/kg) revealed atrophied glomerular
tuft and degeneration of epithelial lining of the renal tu-
bules (Fig. 4a). In addition, dilated blood vessels engorged
with blood cells and perivascular oedema were noticed
(Fig. 4b). Light microscopic examination of the kidney of
mice treated with VPA and RJ (50 mg/kg) revealed regener-
ation of renal tubules and glomeruli but still with slight
inflammatory cells infiltration (Fig. 4c and d). While the
kidney of mice treated with VPA and RJ (100 mg/kg) revealed
nearly normal structure of renal corpuscles and renal tu-
bules (Fig. 4e and f).
3.3. Transmission electron microscopic analysis
3.3.1. Renal corpuscles
The renal corpuscles of control normal mice appear as
dense round tufts of capillaries. The outer layer ofb
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visceral layer applies closely to the glomerular capillaries.
Podocytes surround the capillaries. Each capillary loop is
lined with endothelial cells. Podocytes give rise to primary
processes which in turn give numerous secondary foot
processes or pedicels that rest on a thin basal lamina. Each
podocyte has a large nucleus and abundant cytoplasm. The
pedicels are separated by slit pores. The filtration barrier
includes thin basal lamina. The mesangium comprises two
components, mesangial cells and mesangial substance and
provides support for several capillary loops. The mesangial
cell is characterized by large heterochromatic nucleus. The
mesangial matrix largely encloses the mesangial cells
(Fig. 5a).
Electron micrographs of kidney sections of mice given VPA
for three weeks showed renal corpuscles with marked
degeneration of almost structures of glomeruli, including
some vacuoles in mesangial cells, segmented nuclei and
irregular basal lamina (Fig. 5b). The mesangial cell appeared
vacuolated with dark mesangial substance. Moreover, the
mesangial matrix showedmarked expansion (Fig. 5c), marked
thickening of the basal lamina and fusion of foot processes
were also noticed (Fig. 5d).
After treatment with RJ “at a dose of 100 mg/kg” in
concomitant with VPA, the renal corpuscle of mice showed
marked amelioration of almost structures including the
podocytes, mesangial cells retained their normal structure
and the basal lamina appeared thin compared to that of mice
treated with valproic acid alone (Fig. 5e).
3.3.2. Renal tubules
The normal proximal tubule cells have a brush border of
numerous microvilli. The nucleus is spherical in shape.
Numerousmitochondria fill the cytoplasm, the basal lamina is
thin and the basal infoldings run upwards among the mito-
chondria (Fig. 6a). The proximal tubules of mice given VPA
(100 mg/kg) for three weeks showed dissolution and degener-
ation of some parts of the cytoplasm, degeneration of micro-
villi on the apical parts of some cells, in addition to increased
lysosomes (Fig. 6b). The most pronounced feature revealed
marked thickening of the basal lamina and vacuolation (Fig. 6c
and d). Moreover pyknotic nucleus and condensed mitochon-
dria were observed (Fig. 6e). The most damaged organelle, the
mitochondria, showed swelling (Fig. 6c). Treatment with RJ “at
a dose of 100mg/kg” in concomitant with VPA showedmarked
reduction of basal lamina thickness and the apical cell mem-
brane and mitochondria appeared normal but irregular nu-
cleus and some cytoplasmic vacuolation were still observed.
However, the cytoplasmic changes were milder than those
seen in VPA treated group (Fig. 6f).
3.3.3. Distal tubules
The distal tubules of normal control mice showed normal
structure, few or no microvilli and deep infoldings embracing
elongated, spherical or filamentous mitochondria were
observed (Fig. 7a). In VPA treated group, the distal tubule cells
attained obliterated lumen and vacuolated lining epithelium.
The basal infoldings if appeared were shorter. Some damaged
mitochondria were also observed. The nuclei appeared
normal (Fig. 7b and c).After administration of royal jelly (100 mg/kg) with VPA,
the basal infoldings of the distal tubules extended deeply in
the cytoplasm among the mitochondria. Regular basal lamina
and restoration of the number of mitochondria were found
(Fig. 7d).4. Discussion
Epilepsy is one of the most prevalent neurological diseases
affecting approximately 50 million people throughout the
world (El-Sayyad et al., 2013). Many of the antiepileptic
drugs have been found to be mutagenic and teratogenic in
laboratory animals (Biswas et al., 2004). Valproic acid (VPA),
a frequently used drug for the treatment of epilepsy, has
been used worldwide. However, it causes mild to severe side
effects and may lead to death (Baran et al., 2004). The pre-
sent study was designed to investigate the protective role of
royal jelly (RJ) against the cytogenotoxicity and histopatho-
logical alterations of VPA in mice on light and ultrastruc-
tural levels. VPA effects are associated with several
biochemical/molecular modes of action that have been put
forward to account for VPA action, such as interference with
folateemethionine metabolic pathways (Dawson et al.,
2006), activity as a histone deacetylase inhibitor (Eikel
et al., 2006), alteration of gene expression (Okada et al.,
2005), generation of reactive intermediates via lip-
oxygenases or the prostaglandin synthetase co-oxidation
pathway (Miranda et al., 1994), altered antioxidant enzyme
activities (Graf et al., 1998) or increase in the formation of
toxic VPA metabolites (Baran et al., 2004) such as 2, 4-diene-
VPA which can form glutathione conjugate altering gluta-
thione homeostasis (Tabatabaei and Abbott, 1999). In addi-
tion, Tabatabaei et al. (1997) indicated that the increased
flux of oxygen free radicals during the VPA metabolism
leads to nuclear DNA damage, resulting in ensuing cell
death. Furthermore, another study showed that free radi-
cals play an important role as regulatory mediator in
cellular signaling processes. Excessive amount of free radi-
cals production has been related with an increase in
oxidative stress described in series of treatment with VPA in
epileptic patients (Martinez-Ballesteros et al., 2004).
The present investigation showed mice treated with VPA
had increase in number of chromosomal abnormalities and
decrease in mitotic index of bone marrow cells. The chro-
mosomal aberrations induced after treatment with VPA
were structural and numerical aberrations. These results
were in agreement with previous studies which reported a
significant increase in chromosomal aberration rates in
adults treated with antiepileptic drugs (Denli et al., 2000)
and in epileptic children undergoing long-term antiepileptic
drug (Curatolo et al., 1986). Recently, Witczak et al. (2010)
indicated that an increase in sister chromatid exchange
frequency and in the frequency of chromosome aberrations
(including chromosome gaps) was observed in pregnant
women when received different antiepileptic drugs in
mono- and poly-therapy.
Our results suggested that valproic acid was capable of
being genotoxic and cytotoxic because administration of
VPA increased chromosomal abnormalities and decreased
Fig. 3 e (a) A photomicrograph of kidney section of normal control mice showing the glomerulus (G), Bowman’s capsule
(BW), in addition to proximal tubules (P), distal tubules (D) and collecting tubules (C) (H&E 3100). (b) A photomicrograph of
kidney section of normal mice administered royal jelly (200 mg/kg) showing hyperemic glomerulus (G), inflammatory cells
infiltration (IF) and dilated tubules (T) (H&E 3400). (c) A photomicrograph of kidney section of mice given valproic acid
(100 mg/kg) for 3 weeks showing a periglomerular oedema (O) with inflammatory cells infiltration (IF), hyperemic
glomerulus (HY) and karyomegally of some epithelial cells lining the renal tubules ([) (H&E 3400). (d) A photomicrograph of
kidney section of mice given valproic acid (100 mg/kg) for 3 weeks showing dilated blood vessel congested with blood cells
(white arrow) and perivascular oedema (O) with inflammatory cells infiltration (IF) (H&E 3400). (e) A photomicrograph of
kidney section of mice given valproic acid (100 mg/kg) for 3 weeks showing karyomegaly of some epithelial cells lining the
renal tubules (thin arrow) and adhesion of the glomerular tuft with Bowman’s capsule (thick arrow) (H&E 3400). (f) A
photomicrograph of kidney section of mice given valproic acid (100 mg/kg) for 3 weeks showing hyperemic glomerulus (HY)
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Fig. 4 e (a) A photomicrograph of kidney section of mice treated with valproic acid (100 mg/kg) and royal jelly (200 mg/kg) for
3 weeks showing atrophied glomerular tuft (G), widening of the Bowman’s space (thin arrow) and degeneration of the
epithelial lining of the renal tubules (thick arrow) (H&E 3400). (b) A photomicrograph of kidney section of mice treated with
valproic acid (100mg/kg) & royal jelly (200mg/kg) for 3 weeks showing dilated blood vessel ([) engorged with blood cells and
perivascular oedema (O) (H&E 3400). (c & d) Photomicrographs of kidney sections of mice treated with valproic acid (100 mg/
kg) & royal jelly (50 mg/kg) for 3 weeks showing nearly normal renal tubules (T) and glomeruli (G) but inflammatory cell
infiltration (IF) is still present. c (H&E 3100); d (H&E 3400). (e) A photomicrograph of kidney section of mice treated with
valproic acid (100 mg/kg) & royal jelly (100 mg/kg) for 3 weeks showing almost normal renal tubules (T) (H&E 3400). (f) A
photomicrograph of kidney section of mice treated with valproic acid (100 mg/kg) & royal jelly (100 mg/kg) for 3 weeks
showing almost normal proximal tubules (P), distal tubules (D) and glomeruli (G) (H&E 3100).
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that examined the genotoxicity of valproic acid by
analyzing sister chromatid exchanges in peripheral lym-
phocytes from patients treated with valproic acid hadand swelling of renal tubules (T) (H&E3400). (g) A photomicrogra
for 3 weeks showing inflammatory cells infiltration in the inter
3400). (h) A photomicrograph of kidney section of mice given v
endothelium of intertubular blood vessels is degenerated and t
perivascular odema (O) and inflammatory cells infiltration (IF) (shown contradictory results. Sister chromatid exchanges
occur via the homologous recombination (HR) repair
pathway and are used as an indicator of chromosomal
stability after exposure to a potentially mutagenic agentph of kidney section of mice given valproic acid (100 mg/kg)
tubular space (Y) and damaged dilated tubules (T) (H&E
alproic acid (100 mg/kg) for 3 weeks showing that the
he muscle fibers show hydropic degeneration (Y),
H&E 3400).
Fig. 5 e (a) Electron micrograph of kidney section of control mice showing podocytes (P) resting on the basal lamina (BL) and
surrounding the capillary loops. Each capillary loop is lined by endothelial cells. Mesangial cells (MC) and Mesangial
substance (MS) support the capillary loops. Scale bar [ 2 mm. (b) Electron micrograph of kidney section of mice given
valproic acid (100 mg/kg) for 3 weeks showing renal corpuscle with marked degeneration of almost structures of glomerulus
including some vacuoles (V) in mesangial substance (MS), segmented nucleus (N) and irregular basal lamina (BL). Scale
bar[ 2 mm. (c) Electron micrograph of kidney section of mice given valproic acid (100 mg/kg) for 3 weeks showing vacuoles
(V), irregular heterochromatic nucleus (N), dark cytoplasm of mesangial cell (MC), the expansion of mesangial substance
(MS) and basal lamina (BL). Scale bar[ 2 mm. (d) Electron micrograph of kidney section of mice given valproic acid (100 mg/
kg) for 3 weeks showing thick and irregular of basal lamina (BL), podocytes (P) and vacuoles (V). Scale bar[ 2 mm. (e) Electron
micrograph of kidney section of mice treated with valproic acid (100 mg/kg) and royal jelly (100 mg/kg) for 3 weeks showing
basal lamina (Y), mesangial cell (MC), podocyte (P), capillary lumen (CL) and red blood cells (RBCs). Note the appearance of
nucleus (N) with dark clumbs of heterochromatin. Scale bar [ 2 mm.
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that valproic acid may contribute to genomic instability,
because a growing body of evidence demonstrates
that valproic acid alters chromatin structure because it can
function as a histone deacetylase inhibitor, leading to the
acetylation of histone tails (Wu et al., 2010). Also,
VPA further induced a depletion of several members of the
structural maintenance of chromatin (SMC) proteins,
SMC-associated proteins, DNA methyltransferase and
heterochromatin proteins (Marchion et al., 2005).
This change in the chromatin structure relaxes the
conformation of DNA, making it more susceptible to
DNA damage, including double-strand breaks
(Coyle et al., 2005).
The present study revealed marked histological changes
in the kidney of VPA-treated mice. These changes were
apparent in both renal corpuscles and tubules. The most
prominent signs of devastation observed in the renal cor-
puscles were glomerular atrophy, mesangial proliferation
and corpuscular adhesion with glomerular tufts. Besides,
other corpuscles were shrunk with partial degeneration of
glomerular tuft. The kidney tubules were also affected as
indicated by the partial desquamation of epithelial cells lin-
ing the tubules, nuclear degeneration manifested by pyknosis
and intertubular invasion by inflammatory cells. Moreover,
karyomegally and hemorrhage were also observed. Similar
results were described by (Ching-Yuang and Chiang, 1988).
Vallon et al. (2003) also found that, the increase in the size of
the tubules resulted in increased proximal reabsorption,
which in turn caused glomerular hyperfiltration via hyper-
absorption. The hyperfiltration increased glomerular capil-
lary pressure; the glomerular hypertension caused
endothelial mesangial and podocyte injuries with the
increased filtration of proteins to tubular lumen resulting in
tubulointenstial inflammation (Sanchez-Lozada et al., 2004),
which was also seen in the present histological and ultra-
structural study.
Renal tubular dysfunction characterized by glucosuria,
phosphaturia, aminoaciduria and renal tubular acidosis in an
epileptic child receiving VPA was proved by Lenoir et al.
(1981), they suggested that these findings were due to the
direct nephrotoxic effect of VPA. They showed giant mito-
chondria in proximal tubules and abnormal, round granular
inclusions in the cytosol. In addition, Hawkins and Brewer
(1993) also showed evidence of renal tubular dysfunction in
a 10-year-old child who had psychomotor retardation. They
described multifocal interstitial nephritis characterized by
mononuclear cell infiltration around the glomeruli on renal
biopsy material. They also showed that the proximal tubular
epithelium was inflamed and contained giant eosinophilic
inclusions and vacuoles. Mitochondria were excessively
enlarged and the cytoplasm contained lipid droplets but no
immune deposits, these results are in agreement with the
present study.
Ultrastructural examination of the current investigation
showed dark cytoplasm and long processes of mesangial
substance expansion of VPA compared to control mice. This
result is in agreement with El-Sayyad et al. (2013), who re-
ported focal expansion of mesangial region and the podo-
cytes showed either nuclear chromatin condensation ofchromatin or exfoliated in many areas, and the slit mem-
brane structure was deteriorated. Partial deteriorations of
foot processes of podocytes were detected. All of the
mentioned findings illustrated the impairment of renal
function as a result of disease and drug severe toxicity (El-
Sayyad et al., 2013).
The observed findings supported thework ofmany authors
in patients treatedwith sodiumvalproate, carbamazepine and
phenobarbital (Verrotti et al., 2000; Unay et al., 2006) and
experimental mice treated with sodium valporate (Eluma
et al., 1984). The observed findings of nephrotoxicity as illus-
trated by cytological alterations ofmitochondria as well as the
recent studies of sodium valporate (Pourahmad et al., 2012)
may be attributed to the increased production of free radicals
and/or a decreased free radical scavenging capacity. There is
another hypothesis suggesting an involvement of lipid per-
oxidation (Olson et al., 1986). The involvement of peroxidative
injury in sodium valproate induced renal tubular disorder is
based on several lines of evidence. Valproate treatment
decreased the rate of oxidized glutathione released into the
bile (Olson et al., 1986).
The present ultrastructural changes in the proximal tubule
cells included destruction of the microvilli constituting the
brush border, mitochondrial enlargement and increase of
lysosome number, in addition to cytoplasmic vacuolation and
pyknotic nuclei.Moreover, the distal tubule cells appearedwith
ill defined basal infoldings, electron dense mitochondria and
somevacuoles.Thesealterationswere reportedalsobyGossrau
and Graf (1989) who reported a very severe damage to the tu-
bules of the kidney in pregnantmice at a single dose of valproic
acid (500 mg/kg i.p.) which persisted even after 48 h of drug
administration. Renal biopsy indicated giant mitochondria in
the proximal tubular cells and abnormal round granular in-
clusions in the cytosol of tubular cells, podocytes and intersti-
tial cells which were recovered on withdrawal of valproic acid.
In the present study, Administration of RJ in concomitant
with VPA caused a significant decrease in rates of clastoge-
netic changes compared with the VPA treated group. All types
of chromosomal aberrations induced by VPA including breaks,
deletions, fragments, end to end association, centric fusion,
and other multiple damages were found to be reduced by RJ.
The mitotic index was found to be increased over VPA group
for 50 and 100 mg/kg doses, indicating their anti-cytotoxicity
towards VPA.
These results were in agreement with the finding of
C¸avus‚oglu et al. (2009), who stated that supplementation with
RJ resulted in beneficial effects against genotoxicity and
oxidative damages induced by Cadmium in albino mice and
had a protective effect on the chromosomal aberrations
induced. Furthermore, El-Nekeety et al. (2007) determined the
potential protective effect of RJ against the toxic hazards of
fumonisin denoting that RJ had been proved to have oxygen
radical scavenging and antioxidant properties in addition to
the enhancement of glutathione peroxidase formation and
the suppressive effects of lipid peroxidation and free radical
generation. As well, Abd El-Monem (2011) revealed that RJ
caused a significant recovery in antioxidant status and a sig-
nificant inhibition of malondialdehyde production and
ameliorated DNA damage and genotoxicity induced by mala-
thion in rat cells.
Fig. 6 e (a) Electron micrograph of a proximal tubule of control mice showing microvilli (MV), mitochondria (M), regular
nucleus (N) and thin basal lamina (Y). Scale bar[ 2 mm. (b) Electron micrograph of a proximal tubule of mice given valproic
acid (100 mg/kg) for 3 weeks showing lysosomes (LY), mitochondria (M), nucleus (N), dissolution and degeneration of some
parts of the cytoplasm and vacuoles (V) and losing part of their microvilli (MV). Scale bar[ 2 mm. (c) Electron micrograph of a
proximal tubule of mice given valproic acid (100 mg/kg) for 3 weeks showing thickening of the basal lamina (BL), vacuoles
(V), swelled mitochondria (M), irregular nucleus (N) with nuclear pore (NP), lipid droplets (L) and microvilli (MV). Scale
bar [ 2 mm. (d) Electron micrograph of a proximal tubule of mice given valproic acid (100 mg/kg) for 3 weeks showing
condensed mitochondria (M), destructed microvilli (MV), thickening of the basal lamina (BL), vacuoles (V) and dissolution
and degeneration of some parts of the cytoplasm. Scale bar [ 2 mm. (e) Electron micrograph of a proximal tubule of mice
given valproic acid (100 mg/kg) for 3 weeks showing pyknotic nucleus (PN), vacuoles (V), degeneration of microvilli (MV) in
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Fig. 7 e (a) Electron micrograph of a distal tubule cell of control mice showing well-developed basal infoldings (Y) with
numerous mitochondria (M) in between, nucleus (N) and thin basal lamina (BL). Scale bar[ 2 mm. (b) Electron micrograph of
a distal tubule cell of mice given valproic acid (100 mg/kg) for 3 weeks showing vacuoles (V), irregular basal infoldings (Y),
nucleus (N), mitochondria (M) and degeneration of some parts of the cytoplasm. Scale bar[ 2 mm. (c) Electron micrograph of
a distal tubule cell of mice given valproic acid (100 mg/kg) for 3 weeks showing completely destructed mitochondria with
destructed cristae (M) and irregular basal lamina (BL). Scale bar[ 2 mm. (d) Electron micrograph of a distal tubule cell of mice
treated with valproic acid (100 mg/kg) and royal jelly (100 mg/kg) for 3 weeks showing restoration of the normal structure of
mitochondria (M), basal infoldings (Y), basal lamina (BL) and nucleus (N). Scale bar [ 2 mm.
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and 100 mg/kg) revealed a better preservation compared to
those treated with VPA alone. It is also proved by El-Nekeety
et al. (2007), who showed nearly normal structures of the
renal tubules and glomeruli of rats treated with fumonisin
plus RJ. In addition, RJ also decreased necrosis and lympho-
cytic infiltration in rats treated with RJ prophylactic with
cisplatin, also RJ administration caused less degenerative al-
terations and amelioration in the kidney oxidative parame-
ters. This protectionmay be due to antiapoptotic, antioxidant,he apical part of some cells and condensed mitochondria (M). Sca
f mice treated with valproic acid (100 mg/kg) and royal jelly (100
BM), microvilli (MV), mitochondria (M) and irregular nucleus (N).and free radical scavenging activity of royal jelly and its
components (Karadeniz et al., 2011).5. Conclusion
Valproic Acid (VPA) has adverse effects on human health. The
results demonstrated that the administration of VPA to mice
at a dose of 100 mg/kg daily for 3 weeks is capable of inducing
marked chromosomal aberrations, alterations in mitoticle bar[ 2 mm. (f) Electronmicrograph of a proximal tubule
mg/kg) for 3 weeks showing normal basement membrane
Scale bar [ 2 mm.
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using RJ combinedwith VPA, all the histological alteration side
effects in renal tissues were greatly abated with significant
reduction in chromosomal aberrations and elevation in
mitotic index (P < 0.05). RJ at doses of 50 and 100 mg/kg
appearedmore potent in exerting the ameliorative effect than
did the dose of 200 mg/kg.r e f e r e n c e s
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